Prochlorperazine Edisylate Injection
Product Images NDC 23155-294

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 23155-294). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 01

Chemical structure of Prochlorperazine Edisylate, illustrating its molecular arrangement including a chlorophenothiazine core, a piperazine moiety, and associated sulfonate groups as shown.*

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 02

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 03

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 04

Label for Prochlorperazine Edisylate Injection, USP, 10 mg/2 mL (5 mg/mL) in a 2 mL multiple-dose vial. The label indicates use for deep intramuscular or intravenous injection only, not for subcutaneous use. Manufactured by Emcure Pharmaceuticals Ltd. for Avet Pharmaceuticals Inc. Contains barcode, lot, and expiration date fields.*

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 05

Prochlorperazine Edisylate Injection, USP, 10 mg/2 mL (5 mg/mL) packaged in twenty-five 2 mL multiple-dose vials. The label indicates it is for deep intramuscular or intravenous use only, not for subcutaneous use, and must be protected from light. Manufactured by Emcure Pharmaceuticals Ltd. and labeled by Avet Pharmaceuticals Inc.*

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 06

Prochlorperazine Edisylate Injection, USP 10 mg/2 mL (5 mg/mL) in multiple-dose vials, labeled for intramuscular or intravenous use only. The label includes storage instructions, manufacturer Emcure Pharmaceuticals Ltd., and is marketed by Avet Pharmaceuticals Inc. The package contains ten 2 mL vials with warnings against subcutaneous and pediatric surgical use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.